{"id":2852,"date":"2020-04-09T05:30:00","date_gmt":"2020-04-09T05:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/starkt-kassaflode-trots-paverkan-av-covid-19\/"},"modified":"2020-04-09T05:30:00","modified_gmt":"2020-04-09T05:30:00","slug":"starkt-kassaflode-trots-paverkan-av-covid-19","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/starkt-kassaflode-trots-paverkan-av-covid-19\/","title":{"rendered":"Starkt kassafl\u00f6de trots p\u00e5verkan av Covid-19"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>F\u00d6RSTA KVARTALET 2020 (JAN \u2013 MAR)<\/strong><\/div>\n<ul>\n<li>\n<p><span><span><span><span><span>Total f\u00f6rs\u00e4ljning (inklusive kapitalvaror) minskade med 3 procent och uppgick till 46,5 MSEK (47,7). Minskningen motsvarar 6 procent i lokala valutor. Segment f\u00f6rs\u00e4ljning utan kapitalvaror minskade under kvartalet med 6 procent och uppgick till 44,2 MSEK (46,8). Minskningen motsvarar 9 procent i lokala valutor. <\/span><\/span><\/span><\/span><\/span><\/p>\n<\/li>\n<li><span><span><span><span><span>Varm perfusion stod f\u00f6r 27 procent (43) av f\u00f6rs\u00e4ljningen utan kapitalvaror. F\u00f6rs\u00e4ljningen av varor f\u00f6r varm perfusion p\u00e5verkades under mars m\u00e5nad dels av att f\u00e4rre EVLP:er utf\u00f6rdes, dels av att vissa order inte kunde levereras till klinikerna d\u00e5 de endast mottog Covid-19 relaterade artiklar.<\/span><\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span><span><span>R\u00f6relseresultatet f\u00f6re avskrivningar (EBITDA) uppgick till 7,6 MSEK (3,2) motsvarande en EBITDA-marginal om 16 procent (7). R\u00f6relseresultatet f\u00f6rsta kvartalet 2020 har p\u00e5verkats positivt av uppl\u00f6sning av kostnadsreserveringar om 2,5 MSEK (-5,5) avseende koncernens aktiebaserade bonusprogram f\u00f6r anst\u00e4llda utanf\u00f6r Sverige. Justerat f\u00f6r denna reservering uppg\u00e5r EBITDA f\u00f6r f\u00f6rsta kvartalet till 5,1 MSEK (8,8), motsvarande en EBITDA-marginal om 11 procent (18).<\/span><\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span><span><span>R\u00f6relseresultatet uppgick till 0 MSEK (-1,9), efter att avskrivningar om 7,5 MSEK (5,1) belastat kvartalet. Justerat f\u00f6r effekten av aktiebaserade bonusprogram uppgick r\u00f6relseresultatet till -2,5 MSEK (3.7).<\/span><\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span><span><span>Nettoresultatet uppgick till 6,5 MSEK (-0,3), vilket gav ett resultat per aktie om 0,25 SEK (-0,01).<\/span><\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span><span><span>Kassafl\u00f6<\/span><\/span><span><span>det fr\u00e5<\/span><\/span><span><span>n den l<\/span><\/span><span><span>\u00f6pande verksamheten uppgick under kvartalet till 9,2 MSEK (0,1). Kassafl\u00f6det fr\u00e5n investeringsverksamheten uppgick till -15,9 MSEK (-11,7 MSEK). Likvida medel vid kvartalets slut uppgick till 158,7 MSEK, en minskning med 1,3 MSEK gentemot vid \u00e5rets b\u00f6rjan.<\/span><\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span><span><span>Den vidareutvecklade och mer anv\u00e4ndarv\u00e4nliga Perfadex<sup>\u00ae<\/sup> Plus <\/span><\/span><span>med Click Port har lanserats i hela v\u00e4rlden.<\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span><span>En XPS\u2122 har f\u00f6r f\u00f6rsta g\u00e5ngen levererats till ett pediatriskt (barn) sjukhus i Rom, Italien. <\/span><span><span>Vid periodens utg\u00e5ng hade 52 kliniker tillg\u00e5ng till XPS\u2122 eller LS\u2122.<\/span><\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span>Bolagets studier f\u00f6r PrimECC<sup>\u00ae<\/sup> och hj\u00e4rtpreservation inf\u00f6r transplantation i Europa \u00e4r klara f\u00f6r att inkludera de f\u00f6rsta patienterna. Dessa tv\u00e5 studier har inte kunnat starta under det f\u00f6rsta kvartalet p\u00e5 grund av att kliniker i Europa tillf\u00e4lligt pausat alla kliniska studier under Covid-19 epidemin<\/span><\/span><\/span><\/li>\n<\/ul>\n<p><span><span><span>TELEFONKONFERENS<\/span><\/span><\/span><\/p>\n<p><span><span><span><span>VD Magnus Nilsson presenterar rapporten vid en telefonkonferens klockan 11:30 torsdag den 9 april 2020. Telefon: <\/span><span><span>+46 (0)8\u00a0566\u00a0426 51. Ange kod: 52504358#.<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span>G\u00f6teborg den 9 april 2020<br \/>\nXVIVO Perfusion AB (publ)<br \/>\nMagnus Nilsson, VD<\/span><\/span><\/span><\/span><\/p>\n<p>\u00a0<\/p>\n<ul><span><span><br \/>\n<\/span><\/span><\/ul>\n<div class=\"mfn-footer\">\n<p><span><span>F\u00f6r ytterligare information, v\u00e4nligen kontakta: <\/span><\/span><\/p>\n<p><span><span>Christoffer Rosenblad, CFO, +46 735 192159, christoffer.rosenblad@xvivoperfusion.com<br \/>\nMagnus Nilsson, VD, +46 31-788 21 50, magnus.nilsson@xvivoperfusion.com<\/span><\/span><\/p>\n<p><span><span>F\u00f6r ytterligare information om XVIVO Perfusions verksamhet h\u00e4nvisas till bolagets hemsida, www.xvivoperfusion.com<\/span><\/span><\/p>\n<p><span><span>Denna information \u00e4r s\u00e5dan information som Xvivo Perfusion AB (publ) \u00e4r skyldigt att offentligg\u00f6ra enligt EU:s marknadsmissbruksf\u00f6rordning. Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersons f\u00f6rsorg, f\u00f6r offentligg\u00f6rande klockan 7:30 den 9 april 2020.<\/span><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>F\u00d6RSTA KVARTALET 2020 (JAN \u2013 MAR) Total f\u00f6rs\u00e4ljning (inklusive kapitalvaror) minskade med 3 procent och uppgick till 46,5 MSEK (47,7)&#8230;.<\/p>\n","protected":false},"template":"","class_list":["post-2852","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn-report","mfn-news-tag-mfn-report-interim","mfn-news-tag-mfn-report-interim-q1"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Starkt kassafl\u00f6de trots p\u00e5verkan av Covid-19 - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/starkt-kassaflode-trots-paverkan-av-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Starkt kassafl\u00f6de trots p\u00e5verkan av Covid-19 - XVIVO\" \/>\n<meta property=\"og:description\" content=\"F\u00d6RSTA KVARTALET 2020 (JAN \u2013 MAR) Total f\u00f6rs\u00e4ljning (inklusive kapitalvaror) minskade med 3 procent och uppgick till 46,5 MSEK (47,7)....\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/starkt-kassaflode-trots-paverkan-av-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/starkt-kassaflode-trots-paverkan-av-covid-19\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/starkt-kassaflode-trots-paverkan-av-covid-19\\\/\",\"name\":\"Starkt kassafl\u00f6de trots p\u00e5verkan av Covid-19 - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2020-04-09T05:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/starkt-kassaflode-trots-paverkan-av-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/starkt-kassaflode-trots-paverkan-av-covid-19\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/starkt-kassaflode-trots-paverkan-av-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Starkt kassafl\u00f6de trots p\u00e5verkan av Covid-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Starkt kassafl\u00f6de trots p\u00e5verkan av Covid-19 - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/starkt-kassaflode-trots-paverkan-av-covid-19\/","og_locale":"en_US","og_type":"article","og_title":"Starkt kassafl\u00f6de trots p\u00e5verkan av Covid-19 - XVIVO","og_description":"F\u00d6RSTA KVARTALET 2020 (JAN \u2013 MAR) Total f\u00f6rs\u00e4ljning (inklusive kapitalvaror) minskade med 3 procent och uppgick till 46,5 MSEK (47,7)....","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/starkt-kassaflode-trots-paverkan-av-covid-19\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/starkt-kassaflode-trots-paverkan-av-covid-19\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/starkt-kassaflode-trots-paverkan-av-covid-19\/","name":"Starkt kassafl\u00f6de trots p\u00e5verkan av Covid-19 - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2020-04-09T05:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/starkt-kassaflode-trots-paverkan-av-covid-19\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/starkt-kassaflode-trots-paverkan-av-covid-19\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/starkt-kassaflode-trots-paverkan-av-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Starkt kassafl\u00f6de trots p\u00e5verkan av Covid-19"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2852","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}